Inventor
VORNLOCHER HANS-PETER
DE59 patents
⚠️ This page may combine multiple inventors who share the name “VORNLOCHER HANS-PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
23 patentsUS7749978B2Jul 6, 2010
Compositions and methods for inhibiting expression of Huntingtin gene
ALNYLAM PHARMACEUTICALS INC113 citations99
US7718629B2May 18, 2010
Compositions and methods for inhibiting expression of Eg5 gene
ALNYLAM PHARMACEUTICALS INC241 citations99
US7423142B2Sep 9, 2008
Compositions and methods for inhibiting expression of anti-apoptotic genes
ALNYLAM PHARMACEUTICALS INC118 citations99
US7320965B2Jan 22, 2008
Compositions and methods for inhibiting expression of Huntingtin gene
ALNYLAM PHARMACEUTICALS INC208 citations99
US7737265B2Jun 15, 2010
RNAi modulation of HIF-1 and therapeutic uses thereof
ALNYLAM PHARMACEUTICALS INC122 citations98
US7582745B2Sep 1, 2009
Compositions and methods for inhibiting expression of Nav1.8 gene
ALNYLAM PHARMACEUTICALS INC152 citations98
US7786290B2Aug 31, 2010
Double-stranded ribonucleic acid with increased effectiveness in an organism
ALNYLAM PHARMACEUTICALS INC99 citations96
US7928217B2Apr 19, 2011
Nuclease resistant double-stranded ribonucleic acid
ALNYLAM PHARMACEUTICALS INC37 citations92
US7361752B2Apr 22, 2008
RNAi modulation of MLL-AF4 and uses thereof
ALNYLAM PHARMACEUTICALS INC14 citations92
US7528118B2May 5, 2009
RNAi modulation of ApoB and uses thereof
ALNYLAM PHARMACEUTICALS INC21 citations91
US8034793B2Oct 11, 2011
RNAi modulation of MLL-AF4 and uses thereof
ALNYLAM PHARMACEUTICALS INC10 citations84
US10131907B2Nov 20, 2018
Glycoconjugates of RNA interference agents
ALNYLAM PHARMACEUTICALS INC11 citations82
US7994307B2Aug 9, 2011
RNAi modulation of the BCR-ABL fusion gene and uses thereof
ALNYLAM PHARMACEUTICALS INC8 citations80
US10501740B2Dec 10, 2019
Compositions and methods for inhibiting expression of factor V
ALNYLAM PHARMACEUTICALS INC2 citations73
US7846907B2Dec 7, 2010
Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene
ALNYLAM PHARMACEUTICALS INC5 citations73
US7674779B2Mar 9, 2010
RNAi modulation of MLL-AF4 and uses thereof
ALNYLAM PHARMACEUTICALS INC5 citations73
US9441225B2Sep 13, 2016
Compositions and methods for inhibiting expression of factor V
ALNYLAM PHARMACEUTICALS INC2 citations63
US7745418B2Jun 29, 2010
Compositions and methods for inhibiting viral replication
ALNYLAM PHARMACEUTICALS INC4 citations63
US7846908B2Dec 7, 2010
RNAi modulation of TGF-beta and therapeutic uses thereof
ALNYLAM PHARMACEUTICALS INC2 citations62
US7772200B2Aug 10, 2010
iRNA agents targeted to the Rho-A gene
ALNYLAM PHARMACEUTICALS INC2 citations62
US7812150B2Oct 12, 2010
RNAi modulation of Aha and therapeutic uses thereof
ALNYLAM PHARMACEUTICALS INC1 citations59
US9057069B2Jun 16, 2015
Compositions and methods for inhibiting expression of Eg5 gene
ALNYLAM PHARMACEUTICALS INC0 citations52
US7956177B2Jun 7, 2011
dsRNA compositions and methods for treating HPV infection
ALNYLAM PHARMACEUTICALS INC1 citations52
NOVARTIS AG
3 patentsALNYLAM EUROPE AG
3 patentsUS7348314B2Mar 25, 2008
Compositions and methods for inhibiting viral replication
ALNYLAM EUROPE AG45 citations95
US7473525B2Jan 6, 2009
Compositions and methods for inhibiting expression of anti-apoptotic genes
ALNYLAM EUROPE AG53 citations94
US7196184B2Mar 27, 2007
Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene
ALNYLAM EUROPE AG26 citations91
VORNLOCHER HANS-PETER
3 patentsUS8334373B2Dec 18, 2012
Nuclease resistant double-stranded ribonucleic acid
VORNLOCHER HANS-PETER30 citations91
US8658782B2Feb 25, 2014
Compositions and methods for inhibiting expression of factor V
VORNLOCHER HANS-PETER2 citations62
US8993746B2Mar 31, 2015
Nuclease resistant double-stranded ribonucleic acid
VORNLOCHER HANS-PETER3 citations61
VAN HEEKE GINO
3 patentsARROWHEAD PHARMACEUTICALS INC
3 patentsUS10544418B2Jan 28, 2020
RNAi inhibition of alpha-ENaC expression
ARROWHEAD PHARMACEUTICALS INC1 citations73
US11208662B2Dec 28, 2021
RNAi inhibition of alpha-ENaC expression
ARROWHEAD PHARMACEUTICALS INC0 citations62
US9914927B2Mar 13, 2018
RNAi inhibition of alpha-ENaC expression
ARROWHEAD PHARMACEUTICALS INC0 citations52
MPEG LA LLC
2 patentsMPEG LA L L C
2 patentsSAH DINAH WEN-YEE
2 patentsFORST ANDREA
1 patentGIULIANI INTERNATIONAL LTD
1 patentJOHN MATTHIAS
1 patentARROWHEAD RES CORP
1 patentMINA THERAPEUTICS LTD
1 patentSOUTSCHEK JUERGEN
1 patentShowing the top 50 of 59 patents by PatentIndex Score.